Menu
GeneBe

rs368513342

Variant summary

Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM1PM5PP3_Moderate

The NM_000202.8(IDS):c.236C>T(p.Ala79Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000064 in 1,093,191 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A79G) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 22)
Exomes 𝑓: 0.0000064 ( 0 hom. 3 hem. )

Consequence

IDS
NM_000202.8 missense

Scores

6
4
7

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: 7.15
Variant links:
Genes affected
IDS (HGNC:5389): (iduronate 2-sulfatase) This gene encodes a member of the sulfatase family of proteins. The encoded preproprotein is proteolytically processed to generate two polypeptide chains. This enzyme is involved in the lysosomal degradation of heparan sulfate and dermatan sulfate. Mutations in this gene are associated with the X-linked lysosomal storage disease mucopolysaccharidosis type II, also known as Hunter syndrome. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 6 ACMG points.

PM1
In a hotspot region, there are 7 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 4 uncertain in NM_000202.8
PM5
Other missense variant is known to change same aminoacid residue: Variant chrnull-null-null-null is described in UniProt as null.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.891

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
IDSNM_000202.8 linkuse as main transcriptc.236C>T p.Ala79Val missense_variant 2/9 ENST00000340855.11
IDSNM_001166550.4 linkuse as main transcriptc.10C>T p.Arg4Cys missense_variant 2/9
IDSNM_006123.5 linkuse as main transcriptc.236C>T p.Ala79Val missense_variant 2/8
IDSNR_104128.2 linkuse as main transcriptn.405C>T non_coding_transcript_exon_variant 2/9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
IDSENST00000340855.11 linkuse as main transcriptc.236C>T p.Ala79Val missense_variant 2/91 NM_000202.8 P1P22304-1

Frequencies

GnomAD3 genomes
Cov.:
22
GnomAD3 exomes
AF:
0.0000115
AC:
2
AN:
173948
Hom.:
0
AF XY:
0.0000168
AC XY:
1
AN XY:
59520
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000374
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000566
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000640
AC:
7
AN:
1093191
Hom.:
0
Cov.:
29
AF XY:
0.00000836
AC XY:
3
AN XY:
358971
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000286
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000562
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000358
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
22
ExAC
AF:
0.0000330
AC:
4

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMay 22, 2017The p.A79V variant (also known as c.236C>T), located in coding exon 2 of the IDS gene, results from a C to T substitution at nucleotide position 236. The alanine at codon 79 is replaced by valine, an amino acid with similar properties. Another alteration at this position has been reported in the literature in an individual with mild symptoms of Hunter syndrome (Karsten S et al. Hum. Genet. 1998 Dec;103(6):732-5). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Mucopolysaccharidosis, MPS-III-A Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingNatera, Inc.Nov 11, 2019- -
Mucopolysaccharidosis, MPS-II Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingRevvity Omics, RevvityDec 01, 2022- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Pathogenic
0.21
D
BayesDel_noAF
Pathogenic
0.22
Cadd
Benign
19
Dann
Uncertain
1.0
DEOGEN2
Pathogenic
0.84
D;.;D;.
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Benign
0.83
T;D;D;D
M_CAP
Pathogenic
0.32
D
MetaRNN
Pathogenic
0.89
D;D;D;D
MetaSVM
Uncertain
0.64
D
MutationAssessor
Benign
0.47
N;N;.;.
MutationTaster
Benign
1.0
D;D;D;D;D
PrimateAI
Uncertain
0.68
T
PROVEAN
Benign
-1.4
N;N;N;N
REVEL
Pathogenic
0.69
Sift
Benign
0.26
T;T;T;T
Sift4G
Benign
0.44
T;T;T;.
Polyphen
0.54
P;P;B;.
Vest4
0.38
MutPred
0.83
Loss of catalytic residue at A79 (P = 0.1487);Loss of catalytic residue at A79 (P = 0.1487);Loss of catalytic residue at A79 (P = 0.1487);Loss of catalytic residue at A79 (P = 0.1487);
MVP
0.97
MPC
1.7
ClinPred
0.52
D
GERP RS
4.0
Varity_R
0.44
gMVP
0.97

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs368513342; hg19: chrX-148585691; API